Cushman & Wakefield Analyst Ratings
Cushman & Wakefield Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/31/2023 | 49.15% | Raymond James | $12 → $11 | Maintains | Strong Buy |
10/04/2023 | 62.71% | Raymond James | $18 → $12 | Maintains | Strong Buy |
09/18/2023 | 42.37% | Citigroup | $10.5 → $10.5 | Maintains | Neutral |
08/01/2023 | 144.07% | Raymond James | $20 → $18 | Maintains | Strong Buy |
07/24/2023 | 171.19% | Raymond James | $21 → $20 | Maintains | Strong Buy |
07/05/2023 | 42.37% | Morgan Stanley | $19 → $10.5 | Maintains | Overweight |
06/28/2023 | 15.25% | Citigroup | → $8.5 | Reiterates | Neutral → Neutral |
05/19/2023 | 22.03% | Credit Suisse | $15 → $9 | Maintains | Neutral |
05/09/2023 | 15.25% | Goldman Sachs | $11 → $8.5 | Maintains | Neutral |
05/05/2023 | 184.75% | Raymond James | $23 → $21 | Maintains | Strong Buy |
04/17/2023 | 35.59% | UBS | $19 → $10 | Downgrades | Buy → Neutral |
04/11/2023 | 49.15% | Goldman Sachs | $15.5 → $11 | Maintains | Neutral |
04/10/2023 | 49.15% | Goldman Sachs | $15.5 → $11 | Downgrades | Buy → Neutral |
02/01/2023 | — | Wolfe Research | Downgrades | Outperform → Peer Perform | |
01/27/2023 | 116.95% | Goldman Sachs | $14 → $16 | Maintains | Buy |
01/20/2023 | 211.86% | Raymond James | $25 → $23 | Maintains | Strong Buy |
11/08/2022 | 76.27% | Goldman Sachs | $15 → $13 | Maintains | Buy |
11/04/2022 | 238.98% | Raymond James | $30 → $25 | Maintains | Strong Buy |
10/20/2022 | 306.78% | Raymond James | $31 → $30 | Maintains | Strong Buy |
10/19/2022 | 103.39% | Goldman Sachs | $20 → $15 | Maintains | Buy |
07/22/2022 | 320.34% | Raymond James | $35 → $31 | Maintains | Strong Buy |
07/06/2022 | 157.63% | Morgan Stanley | $21 → $19 | Maintains | Overweight |
06/14/2022 | 184.75% | Morgan Stanley | $22.5 → $21 | Maintains | Overweight |
05/19/2022 | 205.08% | Morgan Stanley | $23 → $22.5 | Maintains | Overweight |
05/06/2022 | 374.58% | Raymond James | $32 → $35 | Maintains | Strong Buy |
04/26/2022 | 333.9% | Raymond James | $38 → $32 | Maintains | Strong Buy |
04/19/2022 | 211.86% | Morgan Stanley | $25 → $23 | Maintains | Overweight |
04/05/2022 | 238.98% | Goldman Sachs | → $25 | Initiates Coverage On | → Buy |
03/10/2022 | 279.66% | Wolfe Research | $44 → $28 | Maintains | Outperform |
03/03/2022 | 238.98% | Morgan Stanley | $23.75 → $25 | Maintains | Overweight |
02/25/2022 | 415.25% | Raymond James | $35 → $38 | Maintains | Strong Buy |
01/21/2022 | 374.58% | Raymond James | $31 → $35 | Maintains | Strong Buy |
12/01/2021 | 222.03% | Morgan Stanley | $21.75 → $23.75 | Maintains | Overweight |
11/22/2021 | 320.34% | Raymond James | → $31 | Upgrades | Outperform → Strong Buy |
11/05/2021 | 320.34% | Raymond James | $24 → $31 | Maintains | Outperform |
10/22/2021 | 225.42% | Raymond James | $23 → $24 | Maintains | Outperform |
09/22/2021 | 194.92% | Morgan Stanley | $19 → $21.75 | Maintains | Overweight |
08/06/2021 | 211.86% | Raymond James | $20 → $23 | Maintains | Outperform |
08/06/2021 | 198.31% | Credit Suisse | $20 → $22 | Maintains | Outperform |
07/06/2021 | 157.63% | Morgan Stanley | $18.5 → $19 | Maintains | Overweight |
06/15/2021 | 266.1% | Wolfe Research | → $27 | Initiates Coverage On | → Outperform |
05/17/2021 | 123.73% | B of A Securities | → $16.5 | Downgrades | Neutral → Underperform |
05/12/2021 | 171.19% | Credit Suisse | $19 → $20 | Maintains | Outperform |
05/07/2021 | 171.19% | Raymond James | $19 → $20 | Maintains | Outperform |
05/03/2021 | 150.85% | Morgan Stanley | $15.25 → $18.5 | Maintains | Overweight |
04/27/2021 | 157.63% | Raymond James | $20 → $19 | Maintains | Outperform |
03/10/2021 | 157.63% | Credit Suisse | $17 → $19 | Maintains | Outperform |
02/26/2021 | 171.19% | Raymond James | $18 → $20 | Maintains | Outperform |
01/25/2021 | 110.17% | Goldman Sachs | → $15.5 | Initiates Coverage On | → Neutral |
01/04/2021 | 106.78% | Morgan Stanley | $14 → $15.25 | Maintains | Overweight |
11/17/2020 | 130.51% | Credit Suisse | $14 → $17 | Maintains | Outperform |
11/06/2020 | 144.07% | Raymond James | $17 → $18 | Maintains | Outperform |
10/22/2020 | 130.51% | Raymond James | $18 → $17 | Maintains | Outperform |
09/18/2020 | 144.07% | Raymond James | → $18 | Initiates Coverage On | → Outperform |
09/17/2020 | 144.07% | Raymond James | → $18 | Initiates Coverage On | → Outperform |
05/15/2020 | 89.83% | Credit Suisse | $17 → $14 | Maintains | Outperform |
05/13/2020 | 62.71% | UBS | $24 → $12 | Maintains | Buy |
04/09/2020 | 89.83% | Morgan Stanley | $21 → $14 | Maintains | Overweight |
04/09/2020 | — | JP Morgan | Downgrades | Overweight → Neutral | |
10/18/2019 | 184.75% | B of A Securities | → $21 | Initiates Coverage On | → Neutral |
09/12/2019 | 225.42% | JP Morgan | $22 → $24 | Maintains | Overweight |
07/11/2019 | — | Compass Point | Initiates Coverage On | → Neutral |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
2023年10月31日 | 49.15% | 雷蒙德·詹姆斯 | $12→$11 | 维护 | 强势购买 |
10/04/2023 | 62.71% | 雷蒙德·詹姆斯 | $18→$12 | 维护 | 强势购买 |
09/18/2023 | 42.37% | 花旗集团 | $10.5→$10.5 | 维护 | 中性 |
08/01/2023 | 144.07% | 雷蒙德·詹姆斯 | $20→$18 | 维护 | 强势购买 |
07/24/2023 | 171.19% | 雷蒙德·詹姆斯 | $21→$20 | 维护 | 强势购买 |
07/05/2023 | 42.37% | 摩根士丹利 | $19→$10.5 | 维护 | 超重 |
2023年6月28日 | 15.25% | 花旗集团 | →$8.5 | 重申 | 中性→中性 |
2023年05月19日 | 22.03% | 瑞士信贷 | $15→$9 | 维护 | 中性 |
05/09/2023 | 15.25% | 高盛 | $11→$8.5 | 维护 | 中性 |
05/05/2023 | 184.75% | 雷蒙德·詹姆斯 | $23→$21 | 维护 | 强势购买 |
04/17/2023 | 35.59% | 瑞银集团 | $19→$10 | 评级下调 | 购买→中性 |
04/11/2023 | 49.15% | 高盛 | $15.5→$11 | 维护 | 中性 |
04/10/2023 | 49.15% | 高盛 | $15.5→$11 | 评级下调 | 购买→中性 |
02/01/2023 | - | 沃尔夫研究 | 评级下调 | 超越→同行的表现 | |
2023年1月27日 | 116.95% | 高盛 | $14→$16 | 维护 | 买 |
01/20/2023 | 211.86% | 雷蒙德·詹姆斯 | $25→$23 | 维护 | 强势购买 |
11/08/2022 | 76.27% | 高盛 | $15→$13 | 维护 | 买 |
11/04/2022 | 238.98% | 雷蒙德·詹姆斯 | $30→$25 | 维护 | 强势购买 |
10/20/2022 | 306.78% | 雷蒙德·詹姆斯 | $31→$30 | 维护 | 强势购买 |
10/19/2022 | 103.39% | 高盛 | $20→$15 | 维护 | 买 |
07/22/2022 | 320.34% | 雷蒙德·詹姆斯 | $35→$31 | 维护 | 强势购买 |
07/06/2022 | 157.63% | 摩根士丹利 | $21→$19 | 维护 | 超重 |
2022/06/14 | 184.75% | 摩根士丹利 | $22.5→$21 | 维护 | 超重 |
2022年05月19日 | 205.08% | 摩根士丹利 | $23→$22.5 | 维护 | 超重 |
05/06/2022 | 374.58% | 雷蒙德·詹姆斯 | $32→$35 | 维护 | 强势购买 |
04/26/2022 | 333.9% | 雷蒙德·詹姆斯 | $38→$32 | 维护 | 强势购买 |
04/19/2022 | 211.86% | 摩根士丹利 | $25→$23 | 维护 | 超重 |
04/05/2022 | 238.98% | 高盛 | →$25 | 开始承保 | →购买 |
03/10/2022 | 279.66% | 沃尔夫研究 | $44→$28 | 维护 | 跑赢大盘 |
03/03/2022 | 238.98% | 摩根士丹利 | $23.75→$25 | 维护 | 超重 |
02/25/2022 | 415.25% | 雷蒙德·詹姆斯 | $35→$38 | 维护 | 强势购买 |
2022年01月21日 | 374.58% | 雷蒙德·詹姆斯 | $31→$35 | 维护 | 强势购买 |
12/01/2021 | 222.03% | 摩根士丹利 | $21.75→$23.75 | 维护 | 超重 |
2021年11月22日 | 320.34% | 雷蒙德·詹姆斯 | →$31 | 升级 | 跑赢→强势买入 |
2021年11月05日 | 320.34% | 雷蒙德·詹姆斯 | $24→$31 | 维护 | 跑赢大盘 |
10/22/2021 | 225.42% | 雷蒙德·詹姆斯 | $23→$24 | 维护 | 跑赢大盘 |
09/22/2021 | 194.92% | 摩根士丹利 | $19→$21.75 | 维护 | 超重 |
08/06/2021 | 211.86% | 雷蒙德·詹姆斯 | $20→$23 | 维护 | 跑赢大盘 |
08/06/2021 | 198.31% | 瑞士信贷 | $20→$22 | 维护 | 跑赢大盘 |
07/06/2021 | 157.63% | 摩根士丹利 | $18.5→$19 | 维护 | 超重 |
2021/06/15 | 266.1% | 沃尔夫研究 | →$27 | 开始承保 | →跑赢大盘 |
2021/05/17 | 123.73% | B of A证券 | →$16.5 | 评级下调 | 中性→表现不佳 |
2021/05/12 | 171.19% | 瑞士信贷 | $19→$20 | 维护 | 跑赢大盘 |
05/07/2021 | 171.19% | 雷蒙德·詹姆斯 | $19→$20 | 维护 | 跑赢大盘 |
05/03/2021 | 150.85% | 摩根士丹利 | $15.25→$18.5 | 维护 | 超重 |
04/27/2021 | 157.63% | 雷蒙德·詹姆斯 | $20→$19 | 维护 | 跑赢大盘 |
03/10/2021 | 157.63% | 瑞士信贷 | $17→$19 | 维护 | 跑赢大盘 |
02/26/2021 | 171.19% | 雷蒙德·詹姆斯 | $18→$20 | 维护 | 跑赢大盘 |
2021/01/25 | 110.17% | 高盛 | →$15.5 | 开始承保 | →中性 |
01/04/2021 | 106.78% | 摩根士丹利 | $14→$15.25 | 维护 | 超重 |
11/17/2020 | 130.51% | 瑞士信贷 | $14→$17 | 维护 | 跑赢大盘 |
11/06/2020 | 144.07% | 雷蒙德·詹姆斯 | $17→$18 | 维护 | 跑赢大盘 |
10/22/2020 | 130.51% | 雷蒙德·詹姆斯 | $18→$17 | 维护 | 跑赢大盘 |
09/18/2020 | 144.07% | 雷蒙德·詹姆斯 | →$18 | 开始承保 | →跑赢大盘 |
09/17/2020 | 144.07% | 雷蒙德·詹姆斯 | →$18 | 开始承保 | →跑赢大盘 |
2020/05/15 | 89.83% | 瑞士信贷 | $17→$14 | 维护 | 跑赢大盘 |
2020/05/13 | 62.71% | 瑞银集团 | $24→$12 | 维护 | 买 |
04/09/2020 | 89.83% | 摩根士丹利 | $21→$14 | 维护 | 超重 |
04/09/2020 | - | 摩根大通 | 评级下调 | 超重→中性 | |
2019年10月18日 | 184.75% | B of A证券 | →$21 | 开始承保 | →中性 |
2019/12/09 | 225.42% | 摩根大通 | $22→$24 | 维护 | 超重 |
2019年07月11日 | - | 指南针 | 开始承保 | →中性 |
What is the target price for Cushman & Wakefield (CWK)?
高纬物业的目标价是多少?
The latest price target for Cushman & Wakefield (NYSE: CWK) was reported by Raymond James on October 31, 2023. The analyst firm set a price target for $11.00 expecting CWK to rise to within 12 months (a possible 49.15% upside). 18 analyst firms have reported ratings in the last year.
高纬物业(纽约证券交易所代码:CWK)的最新目标价是由Raymond James于2023年10月31日报道的。这家分析公司将目标价定为11.00美元,预计CWK将在12个月内上涨(可能上涨49.15%)。去年有18家分析公司公布了评级。
What is the most recent analyst rating for Cushman & Wakefield (CWK)?
高纬物业(Cushman&Wakefield)最近的分析师评级是多少?
The latest analyst rating for Cushman & Wakefield (NYSE: CWK) was provided by Raymond James, and Cushman & Wakefield maintained their strong buy rating.
高纬物业(纽约证券交易所代码:CWK)的最新分析师评级由Raymond James提供,高纬物业维持其强劲的买入评级。
When is the next analyst rating going to be posted or updated for Cushman & Wakefield (CWK)?
高纬物业(Cushman&Wakefield)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cushman & Wakefield, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cushman & Wakefield was filed on October 31, 2023 so you should expect the next rating to be made available sometime around October 31, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公开财务报表,与高纬物业的高管和客户交谈,以及收听收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。高纬物业的上一次评级是在2023年10月31日提交的,因此你应该预计下一次评级将在2024年10月31日左右的某个时候公布。
Is the Analyst Rating Cushman & Wakefield (CWK) correct?
高纬物业(Cushman&Wakefield)分析师的评级正确吗?
While ratings are subjective and will change, the latest Cushman & Wakefield (CWK) rating was a maintained with a price target of $12.00 to $11.00. The current price Cushman & Wakefield (CWK) is trading at is $7.38, which is out of the analyst's predicted range.
虽然评级是主观的,并将发生变化,但高纬物业(Cushman&Wakefield)最新的评级维持不变,目标价在12.00美元至11.00美元之间。高纬物业目前的股价为7.38美元,超出了分析师的预期区间。